|
| 30365818 | Ethacrynic acid decreases expression of proinflammatory intestinal wall cytokines and ameliorates gastrointestinal stasis in murine postoperative ileus. | Clinics (Sao Paulo) | 2018 |
| 28215131 | Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial. | Crit Care Resusc | 2017 |
| 26863125 | THE EPITHELIUM AS A TARGET IN SEPSIS. | Shock | 2016 |
| 27776698 | Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice. | J Vasc Surg | 2016 |
| 24371250 | Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure. | J Intensive Care Med | 2015 |
| 26376246 | Integrated Critical Care Organizations: A Personal View. | Crit Care Med | 2015 |
| 25560289 | Cytopathic hypoxia and sepsis: is mitochondrial dysfunction pathophysiologically important or just an epiphenomenon. | Pediatr Crit Care Med | 2015 |
| 24022070 | Animal models of sepsis. | Virulence | 2014 |
| 25672458 | Analyzing the value of monitoring duodenal mucosal perfusion using photoplethysmography. | Crit Care | 2014 |
| 25190187 | Strategies to improve drug development for sepsis. | Nat Rev Drug Discov | 2014 |
| 25029244 | HMGB1 as a drug target in staphylococcal pneumonia. | Crit Care | 2014 |
| 24836806 | Nitric oxide synthase and vascular dysfunction in sepsis: should we target nitric oxide synthase 1, nitric oxide synthase 2, both, or neither? | Crit Care Med | 2014 |
| 24534975 | Acute pancreatitis: a lame duct problem?*. | Crit Care Med | 2014 |
| 24599095 | p-Hydroxyphenylpyruvate, an intermediate of the Phe/Tyr catabolism, improves mitochondrial oxidative metabolism under stressing conditions and prolongs survival in rats subjected to profound hemorrhagic shock. | PLoS One | 2014 |
| 23979366 | Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective. | Crit Care Med | 2013 |
| 22175298 | L-arginine is a radioprotector for hematopoietic progenitor cells. | Radiat Res | 2012 |
| 23351230 | Pathophysiology of perioperative anaemia. | Best Pract Res Clin Anaesthesiol | 2012 |
| 22829588 | Identification of a novel pathway of transforming growth factor-β1 regulation by extracellular NAD+ in mouse macrophages: in vitro and in silico studies. | J Biol Chem | 2012 |
| 22249033 | Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis. | Crit Care Med | 2012 |
| 22425854 | Pharmacological effects of inhaled methane: plausible or not? | Crit Care Med | 2012 |
| 22202712 | A comparison of critical care research funding and the financial burden of critical illness in the United States. | Crit Care Med | 2012 |
| 19959189 | Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion. | J Surg Res | 2011 |
| 21828244 | Transcriptomic response of murine liver to severe injury and hemorrhagic shock: a dual-platform microarray analysis. | Physiol Genomics | 2011 |
| 21446966 | Organized staffing directed by intensivists improves outcomes for critically ill patients. | Am J Transplant | 2011 |
| 21217488 | Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion. | J Trauma | 2011 |
| 20230800 | The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. | Biochem Pharmacol | 2010 |
| 21244758 | Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA). | Int J Immunopathol Pharmacol | 2010 |
| 20451918 | The therapeutic potential of pyruvate. | J Surg Res | 2010 |
| 20664360 | Preconditioning with high mobility group box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance. | J Immunother | 2010 |
| 20194162 | Editorial: Lepromatous leprosy, lipids, and lessons in immunology: what we can learn by using modern methods to study an ancient disease. | J Leukoc Biol | 2010 |
| 18650778 | Drag-reducing hyaluronic acid increases survival in profoundly hemorrhaged rats. | Shock | 2009 |
| 19609124 | Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1. | Crit Care Med | 2009 |
| 19643739 | Editorial: Hemopexin: newest member of the anti-inflammatory mediator club. | J Leukoc Biol | 2009 |
| 19358737 | Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity. | Crit Care | 2009 |
| 19415334 | Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines. | Cell Tissue Res | 2009 |
| 19494177 | Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. | Am J Physiol Regul Integr Comp Physiol | 2009 |
| 19454652 | Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. | J Leukoc Biol | 2009 |
| 19448468 | Peroxisome proliferator activator receptor gamma (PPARgamma) agonists as therapeutic adjuncts in critical illness: efficacy might be suboptimal in elderly patients. | Crit Care Med | 2009 |
| 18835526 | A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. | J Cardiothorac Vasc Anesth | 2009 |
| 19050619 | Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice. | Crit Care Med | 2009 |
| 18948848 | Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury. | Shock | 2009 |
| 19027919 | Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis. | J Surg Res | 2009 |
| 18193822 | Targeting mitochondria. | Acc Chem Res | 2008 |
| 18827799 | Animal models of sepsis and its complications. | Kidney Int | 2008 |
| 18687905 | Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. | J Leukoc Biol | 2008 |
| 18443482 | Ethyl pyruvate. | Curr Opin Anaesthesiol | 2008 |
| 18403588 | Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis. | Am J Pathol | 2008 |
| 17179468 | Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. | J Pharmacol Exp Ther | 2007 |
| 17903310 | Bench-to-bedside review: High-mobility group box 1 and critical illness. | Crit Care | 2007 |
| 17973549 | Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiation. | Radiat Res | 2007 |